Lv3
230 积分 2022-07-11 加入
Diazido nitro pyrazoles: unlocking high-performance primary explosives with binder capabilities
5个月前
已完结
电感耦合等离子体质谱法测定注射用氯化钠中的19种元素杂质 邱晟
5个月前
已完结
Preparation and Characterization of Succinyl‐Chitosan Nanoparticles for Drug Delivery
9个月前
已完结
Efficacy of anti-epidermal growth factor receptor agents in patients with RAS wild-type metastatic colorectal cancer ≥ 70 years
10个月前
已完结
Efficacy of FOLFIRI plus cetuximab vs FOLFIRI plus bevacizumab in 1st-line treatment of older patients with RAS wild-type metastatic colorectal cancer: an analysis of the randomised trial FIRE-3
10个月前
已完结
Efficacy of FOLFIRI plus cetuximab vs FOLFIRI plus bevacizumab in 1st-line treatment of older patients with RAS wild-type metastatic colorectal cancer: an analysis of the randomised trial FIRE-3
10个月前
已完结
Efficacy of anti-epidermal growth factor receptor agents in patients with RAS wild-type metastatic colorectal cancer ≥ 70 years
10个月前
已完结
Inclusion of elderly or frail patients in randomized controlled trials of targeted therapies for the treatment of metastatic colorectal cancer: A systematic review
10个月前
已完结
Tumour location and efficacy of first-line EGFR inhibitors in KRAS/RAS wild-type metastatic colorectal cancer: retrospective analyses of two phase II randomised Spanish TTD trials
10个月前
已完结
VIC Regimen (Vemurafenib/Irinotecan/Cetuximab) Versus Bevacizumab Plus Chemotherapy as First-Line Treatment for BRAF V600E-Mutated Unresectable or Metastatic Colorectal Cancer in Asian Patients: A Prospective Cohort Study
10个月前
已完结
皖公网安备34019202002308
